Quality assurance by a commercial flow cytometry method of leucodepletion of whole blood donations: initial application of universal testing and proposals for a batch-release sampling plan

2000 ◽  
Vol 10 (1) ◽  
pp. 37-48 ◽  
Author(s):  
Barclay ◽  
Walker ◽  
Gibson ◽  
McColl ◽  
Turner
2010 ◽  
Vol 134 (5) ◽  
pp. 771-775 ◽  
Author(s):  
Akiko Sugawara ◽  
Kenneth E. Nollet ◽  
Kentaro Yajima ◽  
Shunnichi Saito ◽  
Hitoshi Ohto

Abstract Context.—Platelet-derived microparticles (PDMPs) probably function in hemostasis, thrombosis, inflammation, and transfusion-related immunomodulation. Objective.—To compare PDMP levels of leukocyte-filtered and unfiltered whole blood during storage. Design.—Ten whole blood donations were collected and processed. Half of each collection was filtered, half remained unfiltered, and both halves were measured for red cell, white cell, and platelet (PLT) content before storage. Samples were drawn on days 0, 1, 2, 3, 5, 7, 14, 21, 28, and 35 and analyzed by flow cytometry. Results.—Leukocyte filtration lowered prestorage PDMP and PLT counts by an average of 72% and 99%, respectively. Prestorage PDMP counts were 123 ± 51/µL in unfiltered whole blood supernatant versus 34 ± 18/µL after filtration. Prestorage PLT counts were 190 ± 49/µL in unfiltered whole blood supernatant versus 2 ± 4/µL after filtration. Moreover, PDMP and PLT counts in filtered whole blood remained low throughout storage, typically below 100/µL. In contrast, unfiltered whole blood PDMP- and PLT-gated events increased approximately 2 log during storage, with the peak number of PLT-gated events tending to coincide with the peak number of PDMP-gated events (4 donors) or to come after the peak number of PDMP-gated events (6 donors). Conclusions.—Leukocyte filtration of whole blood lowers prestorage PDMP and PLT counts. Platelet-derived microparticle and PLT counts remain low throughout 35 days of storage. In contrast, PDMP- and PLT-gated events increase significantly in unfiltered whole blood. The nature of PLT-gated events in stored blood warrants further investigation.


1999 ◽  
Vol 19 (03) ◽  
pp. 134-138
Author(s):  
Gitta Kühnel ◽  
A. C. Matzdorff

SummaryWe studied the effect of GPIIb/IIIa-inhibitors on platelet activation with flow cytometry in vitro. Citrated whole blood was incubated with increasing concentrations of three different GPIIb/IIIa-inhibitors (c7E3, DMP728, XJ757), then thrombin or ADP were added and after 1 min the sample was fixed. Samples without c7E3 but with 0.1 U/ml thrombin had a decrease in platelet count. Samples with increasing concentrations of c7E3 had a lesser or no decrease in platelet count. The two other inhibitors (DMP 725, XJ757) gave similar results. GPIIb/IIIa-inhibitors prevent aggregate formation and more single platelets remain in the blood sample. The agonist-induced decrease in platelet count correlates closely with the concentration of the GPIIb/IIIa inhibitor and receptor occupancy. This correlation may be used as a simple measure for inhibitor activity in whole blood.


Author(s):  
Cecile Braudeau ◽  
Nina Salabert‐Le Guen ◽  
Justine Chevreuil ◽  
Marie Rimbert ◽  
Jerome C. Martin ◽  
...  

Transfusion ◽  
2021 ◽  
Author(s):  
Jean Stanley ◽  
Susan L. Stramer ◽  
Yasuko Erickson ◽  
Julie Cruz ◽  
Jed Gorlin ◽  
...  

Vox Sanguinis ◽  
2002 ◽  
Vol 82 (2) ◽  
pp. 55-60 ◽  
Author(s):  
P. Perez ◽  
C. Bruneau ◽  
M. Chassaigne ◽  
L. R. Salmi ◽  
L. Noel ◽  
...  

2000 ◽  
Vol 9 (4) ◽  
pp. 808-812 ◽  
Author(s):  
Sibylle A. Kozek-Langenecker ◽  
S. Fazal Mohammad ◽  
Takahisa Masaki ◽  
Craig Kamerath ◽  
Alfred K. Cheung

Sign in / Sign up

Export Citation Format

Share Document